KTTAW
Financials
- Market Capitalization 16.0389 M
- Employee 5
- Founded 2020
- CEO N/A
- Website www.pasithea.com
- Headquarter Delaware, United States
- FIGI BBG01018ZGY8
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 7455 |  ICUCW SeaStar Medical Holding Corporation - Warrant | 0.0258 USD | 0.00% | +50.00% | +61.25% | -20.86% | 20.02 M USD | ||
| 7456 |  JSPRW Jasper Therapeutics, Inc. - Warrant | 0.0133 USD | 0.00% | +3.10% | +30.39% | -86.70% | 19.04 M USD | ||
| 7474 |  BIVIW BioVie Inc. - Warrant | 0.5850 USD | 0.00% | +25.81% | +95.20% | +46.43% | 12.22 M USD | ||
| 7484 |  ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0239 USD | 0.00% | +19.50% | +19.50% | -56.23% | 7.88 M USD |
Frequently asked questions about Pasithea Therapeutics Corp. - Warrant
What is the Pasithea Therapeutics Corp. - Warrant stock price today?
The current price of Pasithea Therapeutics Corp. - Warrant (KTTAW) is 0.0081. Over the past 24 hours, the stock has changed by +15.71%. Follow the KTTAW chart for real-time price dynamics.
What is the stock ticker of Pasithea Therapeutics Corp. - Warrant?
Pasithea Therapeutics Corp. - Warrant trades under the ticker KTTAW. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Pasithea Therapeutics Corp. - Warrant stock going up?
KTTAW has changed by -16.49% over the last week, +68.75% over the last month, and -61.43% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Pasithea Therapeutics Corp. - Warrant net income for the last quarter?
Pasithea Therapeutics Corp. - Warrant reported net income of -2.87 M for the last quarter. The previous quarter showed -10.11 M, which means net income changed by +71.62%.
How many employees does Pasithea Therapeutics Corp. - Warrant have?
As of the latest available data, Pasithea Therapeutics Corp. - Warrant has 5 employees. Workforce size can provide additional context about the company's scale and operations.
What is Pasithea Therapeutics Corp. - Warrant EBITDA?
Pasithea Therapeutics Corp. - Warrant EBITDA is -1.79 M, and its EBITDA margin is 18.82 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Pasithea Therapeutics Corp. - Warrant stock?
You can buy Pasithea Therapeutics Corp. - Warrant (KTTAW) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Pasithea Therapeutics Corp. - Warrant stock?
Investing in Pasithea Therapeutics Corp. - Warrant requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KTTAW chart and related analysis on metatrader.com as part of your research.